Co-Authors
This is a "connection" page, showing publications co-authored by CANDELARIA GOMEZ-MANZANO and RAYMOND E SAWAYA.
Connection Strength
0.122
-
Antitumor immune response during glioma virotherapy. Neuro Oncol. 2019 09 06; 21(9):1087-1088.
Score: 0.044
-
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma. J Clin Oncol. 2018 05 10; 36(14):1419-1427.
Score: 0.039
-
Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. Cancer Gene Ther. 2005 Mar; 12(3):284-94.
Score: 0.016
-
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst. 2003 May 07; 95(9):652-60.
Score: 0.014
-
Adenovirus-mediated p16/CDKN2 gene transfer suppresses glioma invasion in vitro. Oncogene. 1997 Oct 23; 15(17):2049-57.
Score: 0.010